electroCore to Report Third Quarter 2026 Financial Results on November 4, 2026
electroCore, Inc. announced it will release its financial results for the third quarter ended September 30, 2026, after market close on November 4, 2026.
Stocks · News reference
electroCore Submits 510(k) Premarket Notification to FDA for Quell Platform
electroCore, Inc. has submitted a 510(k) premarket notification to the FDA seeking clearance for its Quell wearable neuromodulation platform to treat chronic chemotherapy-induced peripheral neuropathy.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- fiscal.ai
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Ecora Royalties PLC Announces Q3 2026 Trading Update
Ecora Royalties reported its Q3 2026 trading results, highlighting a portfolio contribution of $24.8 million and continued progress in deleveraging its balance sheet.
electroCore Announces Findings from US Air Force Research Laboratory fMRI Study on tcVNS
electroCore, Inc. reported findings from a controlled fMRI study conducted by the U.S. Air Force Research Laboratory evaluating the impact of transcutaneous cervical vagus nerve stimulation on visual skill learning.